$1.12
+0.02 (+1.82%)
Performance
1D
—
1W
—
1M
+7.69%
3M
-19.42%
6M
-18.84%
1Y
-18.84%
YTD
-18.84%
Open$1.10
Previous Close$1.10
Day High$1.13
Day Low$1.08
52W High$4.08
52W Low$0.82
Volume—
Avg Volume7.61M
Market Cap287.04M
P/E Ratio—
EPS$-0.08
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.26
Below
RSI (14)
38.1
Neutral
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,243.8% upside
Current
$1.12
$1.12
Target
$37.45
$37.45
$22.27
$37.45 avg
$46.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 246.40M | 264.60M | 65.59M |
| Net Income | -5,579,771 | -5,392,819 | -3,878,355 |
| Profit Margin | -2.3% | -2.2% | -5.9% |
| EBITDA | 24.52M | 25.01M | -4,128,349 |
| Free Cash Flow | — | — | -1,979,346 |
| Rev Growth | -6.9% | -6.9% | +11.6% |
| Debt/Equity | 5.94 | 5.94 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |